|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hung MS, Chen IC, You L, Jablons DM, Li
YC, Mao JH, Xu Z, Hsieh MJ, Lin YC, Yang CT, et al: Knockdown of
Cul4A increases chemosensitivity to gemcitabine through
upregulation of TGFBI in lung cancer cells. Oncol Rep.
34:3187–3195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim JE, Kim SJ, Lee BH, Park RW, Kim KS
and Kim IS: Identification of motifs for cell adhesion within the
repeated domains of transforming growth factor-beta-induced gene,
betaig-h3. J Biol Chem. 275:30907–30915. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y, Wen G, Shao G, Wang C, Lin C,
Fang H, Balajee AS, Bhagat G, Hei TK and Zhao Y: TGFBI deficiency
predisposes mice to spontaneous tumor development. Cancer Res.
69:37–44. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Y, El-Gabry M and Hei TK: Loss of
Betaig-h3 protein is frequent in primary lung carcinoma and related
to tumorigenic phenotype in lung cancer cells. Mol Carcinog.
45:84–92. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wen G, Partridge MA, Li B, Hong M, Liao W,
Cheng SK, Zhao Y, Calaf GM, Liu T, Zhou J, et al: TGFBI expression
reduces in vitro and in vivo metastatic potential of lung and
breast tumor cells. Cancer Lett. 308:23–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ahmed AA, Mills AD, Ibrahim AE, Temple J,
Blenkiron C, Vias M, Massie CE, Iyer NG, McGeoch A, Crawford R, et
al: The extracellular matrix protein TGFBI induces microtubule
stabilization and sensitizes ovarian cancers to paclitaxel. Cancer
Cell. 12:514–527. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li B, Wen G, Zhao Y, Tong J and Hei TK:
The role of TGFBI in mesothelioma and breast cancer: Association
with tumor suppression. BMC Cancer. 12:2392012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Irigoyen M, Pajares MJ, Agorreta J,
Ponz-Sarvisé M, Salvo E, Lozano MD, Pio R, Gil-Bazo I and Rouzaut
A: TGFBI expression is associated with a better response to
chemotherapy in NSCLC. Mol Cancer. 9:1302010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao Y, Shao G, Piao CQ, Berenguer J and
Hei TK: Down-regulation of Betaig-h3 gene is involved in the
tumorigenesis in human bronchial epithelial cells induced by
heavy-ion radiation. Radiat Res. 162:655–659. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shao G, Berenguer J, Borczuk AC, Powell
CA, Hei TK and Zhao Y: Epigenetic inactivation of Betaig-h3 gene in
human cancer cells. Cancer Res. 66:4566–4573. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shimono Y, Zabala M, Cho RW, Lobo N,
Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, et al:
Downregulation of miRNA-200c links breast cancer stem cells with
normal stem cells. Cell. 138:592–603. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu X, Zhang M, Miao J, Wang X and Huang C:
miRNA-4317 suppresses human gastric cancer cell proliferation by
targeting ZNF322. Cell Biol Int. 42:923–930. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mei Q, Li X, Guo M, Fu X and Han W: The
miRNA network: Micro-regulator of cell signaling in cancer. Expert
Rev Anticancer Ther. 14:1515–1527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao X, Zhao H, Diao C, Wang X, Xie Y, Liu
Y, Han J and Zhang M: miR-455-3p serves as prognostic factor and
regulates the proliferation and migration of non-small cell lung
cancer through targeting HOXB5. Biochem Biophys Res Commun.
495:1074–1080. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye MF, Zhang JG, Guo TX and Pan XJ:
MiR-504 inhibits cell proliferation and invasion by targeting LOXL2
in non small cell lung cancer. Biomed Pharmacother. 97:1289–1295.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Liu Z, Fang X and Yang H:
MiR-142-5p suppresses tumorigenesis by targeting PIK3CA in
non-small cell lung cancer. Cell Physiol Biochem. 43:2505–2515.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Tang Z, Wang H, Wu W, Zhou F, Ke H,
Lu W, Zhang S, Zhang Y, Yang S, et al: CXCL6 promotes non-small
cell lung cancer cell survival and metastasis via down-regulation
of miR-515-5p. Biomed Pharmacother. 97:1182–1188. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou Y, Sheng B, Xia Q, Guan X and Zhang
Y: Association of long non-coding RNA H19 and microRNA-21
expression with the biological features and prognosis of non-small
cell lung cancer. Cancer Gene The. 24:317–324. 2017. View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen X, Wang K, Chen J, Guo J, Yin Y, Cai
X, Guo X, Wang G, Yang R, Zhu L, et al: In vitro evidence suggests
that miR-133a-mediated regulation of uncoupling protein 2 (UCP2) is
an indispensable step in myogenic differentiation. J Biol Chem.
284:5362–5369. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Y, Liu R, Yang F, Cheng R, Chen X, Cui
S, Gu Y, Sun W, You C, Liu Z, et al: miR-19a promotes colorectal
cancer proliferation and migration by targeting TIA1. Mol Cancer.
16:532017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mazière P and Enright AJ: Prediction of
microRNA targets. Drug Discov Today. 12:452–458. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ivanov SV, Ivanova AV, Salnikow K,
Timofeeva O, Subramaniam M and Lerman MI: Two novel VHL targets,
TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in
renal clear cell carcinoma and other tumors. Biochem Biophys Res
Commun. 370:536–540. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng
R, Wang Y, Huang J, Xu M, Yan J and Yu J: lncRNA H19/miR-675 axis
represses prostate cancer metastasis by targeting TGFBI. FEBS J.
281:3766–3775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Choi SI, Jin JY, Maeng YS, Kim TI and Kim
EK: TGF-beta regulates TGFBIp expression in corneal fibroblasts via
miR-21, miR-181a, and Smad signaling. Biochem Biophys Res Commun.
472:150–155. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ,
Wang YK, Zeng F, Zhou JH and Zhang YK: High expression of serum
miR-21 and tumor miR-200c associated with poor prognosis in
patients with lung cancer. Med Oncol. 29:618–626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ruvkun G: Clarifications on miRNA and
cancer. Science. 311:36–37. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Re M, Magliulo G, Gioacchini FM,
Bajraktari A, Bertini A, Ceka A, Rubini C, Ferrante L, Procopio AD
and Olivieri F: Expression levels and clinical significance of
miR-21-5p, miR-let-7a and miR-34c-5p in laryngeal squamous cell
carcinoma. Biomed Res Int. 2017:39212582017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chan SH, Wu CW, Li AF, Chi CW and Lin WC:
miR-21 microRNA expression in human gastric carcinomas and its
clinical association. Anticancer Res. 28:907–911. 2008.PubMed/NCBI
|
|
34
|
Zhu M, Huang Z, Zhu D, Zhou X, Shan X, Qi
LW, Wu L, Cheng W, Zhu J, Zhang L, et al: A panel of microRNA
signature in serum for colorectal cancer diagnosis. Oncotarget.
8:17081–17091. 2017.PubMed/NCBI
|
|
35
|
Huo D, Clayton WM, Yoshimatsu TF, Chen J
and Olopade OI: Identification of a circulating microRNA signature
to distinguish recurrence in breast cancer patients. Oncotarget.
7:55231–55248. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang K, Chen M and Wu W: Analysis of
microRNA (miRNA) expression profiles reveals 11 key biomarkers
associated with non-small cell lung cancer. World J Surg Oncol.
15:1752017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang JJ, Liu WQ, Peng JJ, Ma QL, Peng J
and Luo XJ: miR-21-5p/203a-3p promote ox-LDL-induced endothelial
cell senescence through down-regulation of mitochondrial fission
protein Drp1. Mech Ageing Dev. 164:8–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang R and Xia T: Long non-coding RNA
XIST regulates PDCD4 expression by interacting with miR-21-5p and
inhibits osteosarcoma cell growth and metastasis. Int J Oncol.
51:1460–1470. 2017. View Article : Google Scholar : PubMed/NCBI
|
